COM:SANTHERA
Santhera Pharmaceuticals Switzerland
- Stock
Last Close
7.90
22/11 16:30
Market Cap
85.47M
Beta: -
Volume Today
13.43K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -5.76M - | -7.53M 30.76% | 2.93M 138.95% | -33.19M 1,231.36% | -51.27M 54.47% | -53.86M 5.05% | -18.39M 65.85% | -67.46M 266.75% | -54.72M 18.88% | -70.62M 29.06% | 54.78M 177.58% | |
depreciation and amortization | 598K - | 75K 87.46% | 1.12M 1,396% | 3.26M 190.91% | 3.38M 3.62% | 3.74M 10.62% | 4.77M 27.53% | 7.14M 49.59% | 3.72M 47.82% | 9.86M 164.72% | 3.04M 69.16% | |
deferred income tax | -22K - | -5K 77.27% | -26.21M 524,140.00% | -276K 98.95% | -4.58M 1,560.87% | -5.70M 24.35% | -4.41M 22.56% | -3.77M 14.52% | -24.11M 538.88% | |||
stock based compensation | 290K - | 759K 161.72% | 2.04M 168.77% | 4.68M 129.56% | 9.69M 106.85% | 7.43M 23.34% | 6.25M 15.77% | 3.03M 51.57% | 2.76M 8.85% | 5.45M 97.46% | ||
change in working capital | -533K - | 625K 217.26% | -2.51M 502.08% | -1.68M 33.11% | 2.34M 238.96% | 7.80M 233.78% | 6.42M 17.61% | 3.17M 50.61% | 18.49M 482.82% | 9.48M 48.74% | -1.35M 114.26% | |
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | ||||||||||||
other working capital | ||||||||||||
other non cash items | -1.55M - | 15K 100.97% | 239K 1,493.33% | 67K 71.97% | 821K 1,125.37% | 2.73M 233.13% | 7.95M 190.75% | 14.38M 80.84% | 16.48M 14.64% | 15.98M 3.05% | -2.77M 117.31% | |
net cash provided by operating activities | -6.98M - | -6.06M 13.09% | -22.39M 269.29% | -27.14M 21.20% | -39.63M 46.05% | -37.87M 4.46% | 2.60M 106.85% | -43.51M 1,776.69% | -37.36M 14.14% | -29.84M 20.12% | 47.62M 259.58% | |
investments in property plant and equipment | -4K - | -207K 5,075% | -515K 148.79% | -375K 27.18% | -1.40M 272.53% | -21.64M 1,449.18% | -229K 98.94% | -34K 85.15% | -15K 55.88% | -3.96M 26,273.33% | -23.74M 500.18% | |
acquisitions net | ||||||||||||
purchases of investments | -104K - | -84K 19.23% | -13.34M 15,783.33% | |||||||||
sales maturities of investments | 276K - | 12.73M - | 18K 99.86% | 1.60M 8,772.22% | 84K 94.74% | 24K 71.43% | 5.70M 23,645.83% | |||||
other investing activites | -7.50M - | 3M 140% | 3M 0% | |||||||||
net cash used for investing activites | 272K - | -207K 176.10% | -619K 199.03% | -459K 25.85% | -22.24M 4,745.10% | -5.91M 73.43% | 2.79M 147.20% | 1.56M 43.96% | 69K 95.59% | -3.93M 5,798.55% | -18.04M 358.90% | |
debt repayment | -4.73M - | -24.56M 419.00% | -3.50M 85.75% | -18.45M 427.03% | -15.42M 16.42% | |||||||
common stock issued | 428K - | 18.98M 4,335.75% | 84.57M 345.47% | 803K 99.05% | 9.41M 1,071.36% | 25.80M 174.24% | 8.96M 65.28% | 901K 89.94% | 20.35M 2,158.93% | 511K 97.49% | 16.00M 3,032.09% | |
common stock repurchased | -50K - | -172K - | -9.57M 5,462.21% | -3.41M 64.33% | -1.84M 46.18% | -922K 49.81% | -56K 93.93% | |||||
dividends paid | -24.56M - | -32.66M 33.00% | ||||||||||
other financing activites | -909K - | -324K 64.36% | -1.94M 499.69% | 57.27M - | -1.74M 103.03% | 1.74M 200.17% | 72.29M 4,052.15% | 61.89M 14.39% | 31.93M 48.41% | |||
net cash used provided by financing activities | -531K - | 18.66M 3,614.31% | 82.63M 342.80% | 631K 99.24% | 57.11M 8,950.40% | 20.64M 63.85% | 4.13M 80.00% | 23.15M 460.67% | 46.02M 98.80% | 13.99M 69.59% | -124K 100.89% | |
effect of forex changes on cash | -4K - | -197K - | -79K 59.90% | 144K 282.28% | -94K 165.28% | -126K 34.04% | -150K 19.05% | 65K 143.33% | -73K 212.31% | |||
net change in cash | -7.24M - | 12.39M 271.17% | 59.42M 379.57% | -27.04M 145.51% | -4.62M 82.92% | -23.22M 402.68% | 9.39M 140.42% | -18.95M 301.84% | 8.80M 146.43% | -19.86M 325.70% | 29.02M 246.14% | |
cash at beginning of period | 12.28M - | 5.04M 58.94% | 17.43M 245.66% | 76.86M 340.83% | 49.81M 35.19% | 45.20M 9.27% | 21.97M 51.39% | 31.36M 42.72% | 12.41M 60.42% | 21.21M 70.88% | 1.35M 93.62% | |
cash at end of period | 5.04M - | 17.43M 245.66% | 76.86M 340.83% | 49.81M 35.19% | 45.20M 9.27% | 21.97M 51.39% | 31.36M 42.72% | 12.41M 60.42% | 21.21M 70.88% | 1.35M 93.62% | 30.37M 2,144.64% | |
operating cash flow | -6.98M - | -6.06M 13.09% | -22.39M 269.29% | -27.14M 21.20% | -39.63M 46.05% | -37.87M 4.46% | 2.60M 106.85% | -43.51M 1,776.69% | -37.36M 14.14% | -29.84M 20.12% | 47.62M 259.58% | |
capital expenditure | -4K - | -207K 5,075% | -515K 148.79% | -375K 27.18% | -1.40M 272.53% | -21.64M 1,449.18% | -229K 98.94% | -34K 85.15% | -15K 55.88% | -3.96M 26,273.33% | -23.74M 500.18% | |
free cash flow | -6.98M - | -6.27M 10.17% | -22.91M 265.31% | -27.51M 20.11% | -41.03M 49.13% | -59.51M 45.03% | 2.37M 103.98% | -43.54M 1,940.41% | -37.37M 14.17% | -33.80M 9.57% | 23.88M 170.65% |
All numbers in (except ratios and percentages)